UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

BMC medicine, 2022-01, Vol.20 (1), p.2-15, Article 2

2022

Link zum Volltext

Verfügbarkeit prüfen

Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany

PloS one, 2019-08, Vol.14 (8), p.e0220848-e0220848

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database

PloS one, 2020-01, Vol.15 (1), p.e0228020-e0228020

2020

Link zum Volltext

Verfügbarkeit prüfen

Antidepressants and the risk of death in older patients with depression: A population-based cohort study

PloS one, 2019-04, Vol.14 (4), p.e0215289-e0215289

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

PloS one, 2020-05, Vol.15 (5), p.e0231846-e0231846

2020

Link zum Volltext

Verfügbarkeit prüfen

Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer

BMC health services research, 2019-01, Vol.19 (1), p.30-30, Article 30

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes

Journal of primary care & community health, 2022-01, Vol.13, p.21501319211063726-21501319211063726

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink

BMJ open, 2023-03, Vol.13 (3), p.e065927-e065927

2023

Link zum Volltext

Verfügbarkeit prüfen

Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?

Frontiers in neurology, 2018-06, Vol.9, p.500-500

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Cardiovascular diabetology, 2024-02, Vol.23 (1), p.57-57

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Cardiovascular diabetology, 2024-03, Vol.23 (1), p.103-103

2024

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia

Journal of clinical psychopharmacology, 2013-12, Vol.33 (6), p.753-758

2013

Link zum Volltext

Verfügbarkeit prüfen

Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study

The American journal of medicine, 2021-05, Vol.134 (5), p.606-613.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Sodium‐glucose co‐transporter‐2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case–control study

Diabetes, obesity & metabolism, 2019-01, Vol.21 (1), p.52-60

2019

Link zum Volltext

Verfügbarkeit prüfen

Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)

Pharmacoepidemiology and drug safety, 2012-11, Vol.21 (11), p.1216-1220

2012

Link zum Volltext

Verfügbarkeit prüfen

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (3), p.630-643

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation

International journal of cardiology, 2024-06, Vol.404, p.131894-131894, Article 131894

2024

Link zum Volltext

Verfügbarkeit prüfen

Letter by Schmedt and Garbe regarding article, "statins and the risk of cancer after heart transplantation"

Circulation (New York, N.Y.), 2013-02, Vol.127 (5), p.e440-e440

2013

Link zum Volltext

Verfügbarkeit prüfen

Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study

JAMA pediatrics, 2015-04, Vol.169 (4), p.391

2015

Link zum Volltext

Verfügbarkeit prüfen

Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list

Deutsches Ärzteblatt international, 2012-02, Vol.109 (5), p.69-75

2012

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Multiple Sclerosis in Germany: A Cohort Study Applying Different Case Definitions Based on Claims Data

Neuroepidemiology, 2017-12, Vol.49 (3-4), p.91-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

Journal of nephrology, 2023-05, Vol.36 (4), p.1135-1167

2023

Link zum Volltext

Verfügbarkeit prüfen

401-P: Development of Predictive Models for Health Care Outcomes of Patients with Chronic Kidney Disease and Type 2 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

870-P: Empagliflozin and the Risk of Gout—Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

269-OR: Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(29)
Humans
(23)
Mortality
(12)
Patients
(12)
Female
(10)
Germany
(10)
Male
(10)
Aged
(9)
Diabetes
(9)
Diabetes Mellitus
(8)
Adult
(7)
Cardiovascular Diseases
(7)
Diabetes Mellitus, Type 2 - Drug Therapy
(7)
General & Internal Medicine
(7)
Germany - Epidemiology
(7)
Pharmacology & Pharmacy
(7)
Retrospective Studies
(7)
Adolescent
(6)
Epidemiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany

Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database

Antidepressants and the risk of death in older patients with depression: A population-based cohort study

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer

Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes

Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink

Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia

Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study

Sodium‐glucose co‐transporter‐2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case–control study

Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database

Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation

Letter by Schmedt and Garbe regarding article, "statins and the risk of cancer after heart transplantation"

Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study

Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list

Incidence of Multiple Sclerosis in Germany: A Cohort Study Applying Different Case Definitions Based on Claims Data

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

401-P: Development of Predictive Models for Health Care Outcomes of Patients with Chronic Kidney Disease and Type 2 Diabetes

870-P: Empagliflozin and the Risk of Gout—Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

269-OR: Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study

Suchergebnisse filtern